Detalles de la búsqueda
1.
Baseline soluble MICA levels act as a predictive biomarker for the efficacy of regorafenib treatment in colorectal cancer.
BMC Cancer;
22(1): 428, 2022 Apr 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-35443621
2.
Final report on plasma ctDNA T790M monitoring during EGFR-TKI treatment in patients with EGFR mutant non-small cell lung cancer (JP-CLEAR trial).
Jpn J Clin Oncol;
52(7): 791-794, 2022 07 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-35323965
3.
Pharmacokinetics of gefitinib in elderly patients with EGFR-mutated advanced non-small cell lung cancer: a prospective study.
BMC Pulm Med;
22(1): 454, 2022 Nov 30.
Artículo
en Inglés
| MEDLINE | ID: mdl-36451169
4.
Alteration in the Plasma Concentrations of Endogenous Organic Anion-Transporting Polypeptide 1B Biomarkers in Patients with Non-Small Cell Lung Cancer Treated with Paclitaxel.
Drug Metab Dispos;
48(5): 387-394, 2020 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-32114508
5.
High-throughput method to analyze tegafur and 5-fluorouracil in human tears and plasma using hydrophilic interaction liquid chromatography/tandem mass spectrometry.
Rapid Commun Mass Spectrom;
33(24): 1906-1914, 2019 Dec 30.
Artículo
en Inglés
| MEDLINE | ID: mdl-31323696
6.
Plasma ctDNA monitoring during epidermal growth factor receptor (EGFR)-tyrosine kinase inhibitor treatment in patients with EGFR-mutant non-small cell lung cancer (JP-CLEAR trial).
Jpn J Clin Oncol;
49(6): 554-558, 2019 Jun 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-30809659
7.
Coadministration of cytotoxic chemotherapeutic agents with irinotecan is a risk factor for irinotecan-induced cholinergic syndrome in Japanese patients with cancer.
Int J Clin Oncol;
24(2): 222-230, 2019 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-30244364
8.
Lack of correlation between the costs of anticancer drugs and clinical benefits in Japan.
Cancer Sci;
109(12): 3896-3901, 2018 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-30315613
9.
Organic Cation Transporter 1 Is Responsible for Hepatocellular Uptake of the Tyrosine Kinase Inhibitor Pazopanib.
Drug Metab Dispos;
46(1): 33-40, 2018 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-29089306
10.
A phase I study of farletuzumab, a humanized anti-folate receptor α monoclonal antibody, in patients with solid tumors.
Invest New Drugs;
33(2): 332-40, 2015 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-25380636
11.
Association of VEGFA and CCL4L2 polymorphisms with hand-foot skin reaction and survival of regorafenib in Japanese patients with colorectal cancer.
Cancer Chemother Pharmacol;
2024 Mar 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-38459188
12.
Concomitant polypharmacy is associated with irinotecan-related adverse drug reactions in patients with cancer.
Int J Clin Oncol;
18(4): 735-42, 2013 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-22638624
13.
Associations of HLA-C*01:02 and HLA-B*46:01 with regorafenib-induced erythema multiforme in Japanese patients with metastatic colorectal cancer.
Clin Transl Sci;
16(10): 1741-1747, 2023 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-37424405
14.
A polymorphism in ABCA2 is associated with neutropenia induced by capecitabine in Japanese patients with colorectal cancer.
Cancer Chemother Pharmacol;
92(6): 465-474, 2023 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-37653272
15.
A phase I study of infusional 5-fluorouracil, leucovorin, oxaliplatin and irinotecan in Japanese patients with advanced colorectal cancer who harbor UGT1A1*1/*1,*1/*6 or *1/*28.
Oncology;
82(4): 242-8, 2012.
Artículo
en Inglés
| MEDLINE | ID: mdl-22508373
16.
Relationship of circulating tumor cells to the effectiveness of cytotoxic chemotherapy in patients with metastatic non-small-cell lung cancer.
Oncol Res;
20(2-3): 131-7, 2012.
Artículo
en Inglés
| MEDLINE | ID: mdl-23193919
17.
A case of bronchial asthma as an immune-related adverse event of pembrolizumab treatment for bladder cancer: A case report.
Medicine (Baltimore);
101(2): e28339, 2022 Jan 14.
Artículo
en Inglés
| MEDLINE | ID: mdl-35029177
18.
A phase II study of S-1 and cisplatin with concurrent thoracic radiotherapy followed by durvalumab for unresectable, locally advanced non-small-cell lung cancer in Japan (SAMURAI study): primary analysis.
Ther Adv Med Oncol;
14: 17588359221142786, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-36570411
19.
Prospective analysis of factors precluding the initiation of durvalumab from an interim analysis of a phase II trial of S-1 and cisplatin with concurrent thoracic radiotherapy followed by durvalumab for unresectable, locally advanced non-small cell lung cancer in Japan (SAMURAI study).
Ther Adv Med Oncol;
14: 17588359221116603, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-35923924
20.
Delayed elimination of SN-38 in cancer patients with severe renal failure.
Drug Metab Dispos;
39(2): 161-4, 2011 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-20980446